Oracort E

/ Taro

Apply a small amount to cover the lesion with a thin film, without rubbing. 2-3 times a day after meals and before bedtime. If no improvement is seen within seven days, further evaluation is required.

Adjunctive treatment and temporary relief of pain and symptoms associated with oral inflammatory and ulcerative lesions.

* Hypersensitivity to the active substances or to other amide local anaesthetics or to any of the excipients.
* In the presence of fungal, viral, or bacterial infections of the mouth or throat.

* This medicinal product may cause local adverse reactions. If irritation develops, Oracort E should be discontinued and appropriate therapy instituted.
* If concomitant mucosal infections are present or develop, an appropriate antifungal or antibacterial agent should be used. If a favorable response does not occur promptly, use of Oracort E should be discontinued until the infection has been adequately controlled. If significant regeneration or repair of oral tissues has not occurred in seven days, additional investigation into the etiology of the oral lesion is advised.
* Caution in patients with wounds or traumatized mucosa near the intended site of use. Destruction of mucosa results in increased systemic absorption.
Swallowing may be impeded, and the risk of aspiration may be increased.
See prescribing information for full details.

The following local adverse reactions may occur with corticosteroid-containing dental pastes: burning, itching, irritation, dryness, blistering or peeling not present prior to therapy, perioral dermatitis, allergic contact dermatitis, maceration of the oral mucosa, secondary infection, and atrophy of the oral mucosa.
For full details see prescribing information.

Clinically relevant interactions are very unlikely due to local administration and the amount administered.

For full details see prescribing information.

There are no known cases of intoxication